InfuSystem Holdings (INFU) Long-Term Investments (2021 - 2026)
InfuSystem Holdings (INFU) posted Long-Term Investments of $766000.0 for Q1 2026, up 2.41% on a QoQ basis from $748000.0 in Q4 2025, and down 33.51% year-over-year from $1.2 million in Q1 2025.
InfuSystem Holdings (INFU) Long-Term Investments (2021 - 2026) Analysis & Trends
InfuSystem Holdings' Long-Term Investments history runs 6 years deep, the most recent figure standing at $766000.0 for Q1 2026.
- Quarterly Long-Term Investments fell 33.51% year-over-year to $766000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $766000.0 (down 33.51% YoY) and the FY2025 annual result came in at $748000.0, down 49.49% from the prior year.
- Long-Term Investments was $766000.0 for Q1 2026 at InfuSystem Holdings, up from $748000.0 in the prior quarter.
- Across five years, Long-Term Investments topped out at $2.2 million in Q3 2023 and bottomed at $748000.0 in Q4 2025.
- A 5-year average of $1.4 million and a median of $1.5 million in 2023 frame the typical range for Long-Term Investments.
- Annual changes were most pronounced in 2022 — Long-Term Investments soared 453.52% — and 2025, when it plunged 49.49%.
- InfuSystem Holdings' Long-Term Investments stood at $2.0 million in 2022, then retreated by 26.62% to $1.4 million in 2023, then grew by 2.7% to $1.5 million in 2024, then plunged by 49.49% to $748000.0 in 2025, then gained by 2.41% to $766000.0 in 2026.
- Business Quant data shows INFU's Long-Term Investments at $766000.0 in Q1 2026, $748000.0 in Q4 2025, and $850000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.09 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 285.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 166.25 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 121.00 Mn |
| 10 | InfuSystem Holdings | 179.47 Mn | 177.37 Mn | 19.68 Mn | 766,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 766,000.00 |
| Dec 31, 2025 | 748,000.00 |
| Sep 30, 2025 | 850,000.00 |
| Jun 30, 2025 | 949,000.00 |
| Mar 31, 2025 | 1.15 Mn |
| Dec 31, 2024 | 1.48 Mn |
| Sep 30, 2024 | 1.11 Mn |
| Jun 30, 2024 | 1.71 Mn |
| Mar 31, 2024 | 1.72 Mn |
| Dec 31, 2023 | 1.44 Mn |
| Sep 30, 2023 | 2.17 Mn |
| Jun 30, 2023 | 1.91 Mn |
| Mar 31, 2023 | 1.68 Mn |
| Dec 31, 2022 | 1.97 Mn |
| Dec 31, 2021 | 355,000.00 |
| Jun 30, 2021 | 52,000.00 |